Canada Pension Plan Investment Board Takes $57.72 Million Position in Agilent Technologies, Inc. $A

Canada Pension Plan Investment Board bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 434,573 shares of the medical research company’s stock, valued at approximately $57,724,000.

Other institutional investors have also bought and sold shares of the company. Core Wealth Advisors LLC acquired a new stake in Agilent Technologies during the fourth quarter worth approximately $26,000. SHP Wealth Management bought a new stake in Agilent Technologies in the fourth quarter worth approximately $26,000. Navalign LLC acquired a new position in Agilent Technologies in the fourth quarter valued at approximately $27,000. Cedar Mountain Advisors LLC bought a new position in shares of Agilent Technologies during the 1st quarter worth approximately $27,000. Finally, MV Capital Management Inc. bought a new position in shares of Agilent Technologies during the 4th quarter worth approximately $28,000.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
• Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
• Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.

Analyst Upgrades and Downgrades

A has been the subject of several research analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a research note on Thursday. The Goldman Sachs Group lifted their price target on shares of Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price objective on the stock. Morgan Stanley raised their target price on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, TD Cowen upped their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Stock Up 1.6%

Shares of NYSE A opened at $157.60 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a 50-day moving average price of $139.76 and a 200-day moving average price of $126.85. The stock has a market capitalization of $44.51 billion, a P/E ratio of 31.02, a P/E/G ratio of 2.74 and a beta of 1.25. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.84%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.